These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston. Groopman JE; Mayer KH; Sarngadharan MG; Ayotte D; Devico AL; Finberg R; Sliski AH; Allan JD; Gallo RC Ann Intern Med; 1985 Mar; 102(3):334-7. PubMed ID: 2982305 [TBL] [Abstract][Full Text] [Related]
4. AIDS: a challenge for the public health. Acheson ED Lancet; 1986 Mar; 1(8482):662-6. PubMed ID: 2869356 [TBL] [Abstract][Full Text] [Related]
5. Variation in human T lymphotropic virus III (HTLV-III) antibodies in homosexual men: decline before onset of illness related to acquired immune deficiency syndrome (AIDS). Biggar RJ; Melbye M; Ebbesen P; Alexander S; Nielsen JO; Sarin P; Faber V Br Med J (Clin Res Ed); 1985 Oct; 291(6501):997-8. PubMed ID: 2996691 [TBL] [Abstract][Full Text] [Related]
6. Sexual lifestyle and clinical findings related to HTLV-III/LAV status in homosexual men. Evans BA; Dawson SG; McLean KA; Teece SA; Key PR; Bond RA; Macrae KD; Jesson WJ; Mortimer PP Genitourin Med; 1986 Dec; 62(6):384-9. PubMed ID: 3469139 [TBL] [Abstract][Full Text] [Related]
7. HTLV-I-specific antibody in AIDS patients and others at risk. Robert-Guroff M; Blayney DW; Safai B; Lange M; Gelmann EP; Gutterman JW; Mansell PW; Goedert JL; Groopman JE; Steigbigel NH Lancet; 1984 Jul; 2(8395):128-31. PubMed ID: 6146035 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of antibody to LAV/HTLV-III among homosexual men in Seattle. Collier AC; Barnes RC; Handsfield HH Am J Public Health; 1986 May; 76(5):564-5. PubMed ID: 3008580 [TBL] [Abstract][Full Text] [Related]
9. Relation of HTLV-III seropositivity and lymphadenopathy. Jeffries E; Boyko WJ; Willoughby B; Constance PD; Wiggs B; O'Shaughnessy M; Sharp FR Can Med Assoc J; 1985 Jul; 133(2):111-2. PubMed ID: 2988732 [TBL] [Abstract][Full Text] [Related]
10. Lymphadenopathy and antibodies to HTLV-III in homosexual men. Clinical, laboratory and epidemiological features. Bienzle U; Guggenmoos-Holzmann I; Zwingenberger K; Thommsen R; Ritter K; Uy A; Bayer H; Schneider J; Hunsmann G; Coester CH Klin Wochenschr; 1985 Jul; 63(13):597-602. PubMed ID: 2993734 [TBL] [Abstract][Full Text] [Related]
11. Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam. Coutinho RA; Krone WJ; Smit L; Albrecht-van Lent P; van der Noordaa J; Schaesberg W; Goudsmit J Genitourin Med; 1986 Feb; 62(1):38-43. PubMed ID: 3005159 [TBL] [Abstract][Full Text] [Related]
12. IgG-antibodies to HTLV-III in patients with AIDS, LAS, and persons at risk of AIDS in West Germany. Hehlmann R; Kreeb G; Erfle V; Piechowiak H; Krüger G; Goebel FD Blut; 1985 Jan; 50(1):13-8. PubMed ID: 2981593 [TBL] [Abstract][Full Text] [Related]
13. Diversity of clinical spectrum of HTLV-III infection. Valle SL; Saxinger C; Ranki A; Antonen J; Suni J; Lähdevirta J; Krohn K Lancet; 1985 Feb; 1(8424):301-4. PubMed ID: 2857362 [TBL] [Abstract][Full Text] [Related]
14. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome. Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287 [TBL] [Abstract][Full Text] [Related]
15. Human T-lymphotropic retrovirus type III (HTLV-III) in Danish homosexuals. Lange Wantzin G; Saxinger WC; Weismann K; Gallo RC Acta Derm Venereol; 1985; 65(3):247-50. PubMed ID: 2411083 [TBL] [Abstract][Full Text] [Related]
16. Clinical findings and serological evidence of HTLV-III infection in homosexual contacts of patients with AIDS and persistent generalised lymphadenopathy in London. Gazzard BG; Shanson DC; Farthing C; Lawrence AG; Tedder RS; Cheingsong-Popov R; Dalgleish A; Weiss RA Lancet; 1984 Sep; 2(8401):480-3. PubMed ID: 6147547 [TBL] [Abstract][Full Text] [Related]
17. The Vancouver Lymphadenopathy-AIDS Study: 2. Seroepidemiology of HTLV-III antibody. Jeffries E; Willoughby B; Boyko WJ; Schechter MT; Wiggs B; Fay S; O'Shaughnessy M Can Med Assoc J; 1985 Jun; 132(12):1373-7. PubMed ID: 2988729 [TBL] [Abstract][Full Text] [Related]
18. The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells. Schechter MT; Boyko WJ; Jeffries E; Willoughby B; Nitz R; Constance P; Weaver M; Wiggs B; O'Shaughnessy M Can Med Assoc J; 1985 Aug; 133(4):286-92. PubMed ID: 2990652 [TBL] [Abstract][Full Text] [Related]